Celon Pharma S.A. (WSE:CLN)
Poland flag Poland · Delayed Price · Currency is PLN
19.90
+0.10 (0.51%)
Sep 25, 2026, 12:02 PM CET

Celon Pharma Cash Flow Statement

Millions PLN. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
106.81-79.36-34.45-28.12-39.28-11.61
Depreciation & Amortization
43.0646.2851.8648.9542.4339.38
Other Amortization
---1.061.671.96
Loss (Gain) From Sale of Assets
-2.94-1.4-7.64-10.95-3.48-0.13
Asset Writedown & Restructuring Costs
2.982.98----
Loss (Gain) From Sale of Investments
---4.2---
Loss (Gain) on Equity Investments
22.1734.11-5.55---
Stock-Based Compensation
1.46-1.56---
Other Operating Activities
-126.5230.14-1.4111.862.560.28
Change in Accounts Receivable
-14.14-6.79-1.64-12.54-6.4613.24
Change in Inventory
3.234.07-3.7711.98-15.016.38
Change in Other Net Operating Assets
-8.83-6.17-6.12-30.5512.87-5.56
Operating Cash Flow
27.2923.85-11.34-8.31-4.743.95
Operating Cash Flow Growth
------38.73%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-83.92-54.44-22.79-32.81-33.91-41.35
Sale of Property, Plant & Equipment
0.050.150.681.240.590.17
Cash Acquisitions
-10.93-10.93-16.36---
Investment in Securities
16.3849.38409.5--79.87
Other Investing Activities
-2.64-4.13-9.020.431.85-
Investing Cash Flow
-82.72-21.63-7.49-21.64-31.47-121.05

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---12.75--
Long-Term Debt Issued
-1.351.53---
Total Debt Issued
77.781.351.5312.75--
Short-Term Debt Repaid
------12.84
Long-Term Debt Repaid
--9.7-22.44-26.13-12.43-4.8
Lease Payments
-9.56-9.7-9.69-26.13-12.43-4.8
Total Debt Repaid
-9.56-9.7-22.44-26.13-12.43-17.64
Net Debt Issued (Repaid)
68.23-8.35-20.91-13.37-12.43-17.64
Issuance of Common Stock
0.01-40.5100216
Common Dividends Paid
---4.09-4.6-14.8-3.15
Other Financing Activities
-1.17-1.41-2.19-2.62-1.5-14.3
Financing Cash Flow
67.07-9.7613.32-20.59-28.72180.91

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Miscellaneous Cash Flow Adjustments
-0-0----
Net Cash Flow
11.27-7.54-5.51-50.54-64.89103.82

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-56.63-30.58-34.13-41.13-38.612.6
Free Cash Flow Growth
------
Free Cash Flow Margin
-21.98%-12.63%-16.61%-19.16%-19.91%1.33%
Free Cash Flow Per Share
-1.08-0.58-0.63-0.81-0.760.06
Levered Free Cash Flow
-49.29-25.54-22.36-34.98-18.83-1.33
Unlevered Free Cash Flow
-47.33-24.54-20.81-33.32-17.79-0.36
Free Cash Flow After Leases
-66.18-40.28-43.82-67.25-51.04-2.2

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.171.412.192.621.50.94
Cash Income Tax Paid
--4.35-1.07-0.97-0.52-
Change in Working Capital
-19.74-8.9-11.53-31.11-8.614.07